PRS22 EFFECT OF PATIENTS OUT-OF-POCKET COST ON ADHERENCE AND PERSISTENCE WITH OMALIZUMAB (XOLAIR) THERAPY FOR ALLERGIC ASTHMA
May 1, 2008, 00:00
10.1016/S1098-3015(10)70870-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)70870-6/fulltext
Title :
PRS22 EFFECT OF PATIENTS OUT-OF-POCKET COST ON ADHERENCE AND PERSISTENCE WITH OMALIZUMAB (XOLAIR) THERAPY FOR ALLERGIC ASTHMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70870-6&doi=10.1016/S1098-3015(10)70870-6
First page :
Section Title :
Open access? :
No
Section Order :
628